Risk-Adapted Induction is a therapeutic strategy in transplant immunology that belongs to the class of induction immunosuppression protocols and is distinguished by its customization of initial immunosuppressive agent selection and intensity based on individual recipient and donor risk factors for rejection and complications.
11
Publications
285
Citations
108
Authors
59
Institutions
Publications per year
2017–2026
2
Parents
Publications
11
1–5 of 11
Authors
108
- BL
2
h-index
- RM
1
h-index
- MÁ
1
h-index
- BS
1
h-index
- SL
1
h-index
1–5 of 108
Institutions
59
The University of Texas MD Anderson Cancer Center
Houston, United States
2 h-index
2 publications
22 citations
Goethe University Frankfurt
Frankfurt am Main, Germany
2 h-index
2 publications
79 citations
Massachusetts General Hospital
Boston, United States
1 h-index
1 publications
11 citations
Cleveland Clinic
Cleveland, United States
1 h-index
1 publications
11 citations
Kinston Medical Specialists
Kinston, United States
1 h-index
1 publications
11 citations
University Hospital Augsburg
Augsburg, Germany
1 h-index
1 publications
56 citations
Allegheny General Hospital
Pittsburgh, United States
1 h-index
3 publications
36 citations
Washington University in St. Louis
St Louis, United States
1 h-index
2 publications
22 citations
1–8 of 59
Venues
- Transplantation Proceedings
3 publications · 59 citations
3
h-index
- Leukemia & lymphoma/Leukemia and lymphoma
1 publications · 23 citations
1
h-index
- PubMed
Repository · 1 publications · 30 citations
1
h-index
- Clinical Lymphoma Myeloma & Leukemia
1 publications · 11 citations
1
h-index
- Annals of Hematology
1 publications · 56 citations
1
h-index
1–5